The persistence of louping ill virus in immunosuppressed guinea-pigs.
D000818:Animals; D000906:Antibodies; D001921:Brain / Q000382:microbiology; D002490:Central Nervous System / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004669:Encephalitis Viruses, Tick-Borne / Q000472:pathogenicity; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D007249:Inflammation / Q000382:microbiology; D008146:Louping Ill / Q000188:drug therapy / Q000382:microbiology*; D008590:Meningoencephalitis / Q000473:pathology; D009500:Neutralization Tests; D012756:Sheep; D013154:Spleen / Q000382:microbiology; D013997:Time Factors; D014779:Virus Replication
D000906:Antibodies; D003520:Cyclophosphamide